MIRA
INFORM REPORT
|
Report Date : |
22.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
ALBORZ BULK PHARMACEUTICAL COMPANY |
|
|
|
|
Registered Office : |
No.115, 20th (abtahi) St, Kordestan Highwa, Tehran |
|
|
|
|
Country : |
Iran |
|
|
|
|
Date of Incorporation : |
2002 |
|
|
|
|
Com. Reg. No.: |
182565 |
|
|
|
|
Legal Form : |
Privet Joint
Stock Company |
|
|
|
|
Line of Business : |
Manufacture of Pharmaceutical Raw Material |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Company
Details
Company Name: Alborz Bulk Pharmaceutical Company
Headquarter Address: No.115, 20th (abtahi) St,
Kordestan Highway
Tehran
Iran
Tel: +98 21 88339464
+98 21 88339465
+98 21 88339466
+98 21 88339467
Fax:
+98 21 88339468
Website: www.alborz-bulk.com
E-mail: info@alborz-bulk.com
Registration
& Legal Details
Current Legal Form: Privet Joint Stock Company
Registration Address: No.115, 20th (abtahi) St,
Kordestan Highway
Tehran
Iran
Registration Number:
182565
Registration Date:
2002
Year Established: 2002
Registration Town: Tehran
Capital
Currency:
Iranian Rials
Nominal capital:
36,000,000,000
|
Number of Shares: 36,000,000 |
Type of Shares: None Selected |
|
Issued Shares: - |
Value per share: IRI 1,000.00 |
Shareholders
|
Shareholder Names/ Address |
% of Voting/Non-Voting Capital |
|
Iran Darou Company Tehran Iran |
%27 |
|
Alborz Darou Company Tehran Iran |
%20 |
|
Sobhan Pharm Company Tehran Iran |
%30 |
|
Tolidarou Company Tehran Iran |
%23 |
Principals
Name: Mr. Mohamad Esmaeil Zolfaghari
Position within the company: Chairman
Country of Birth:
Iran
Nationality: Iranian
Can fluently speak:
Farsi- English
Name: Mr. Hossien Sobhani
Position within the company:
Vice Chairman
Country of Birth:
Iran
Nationality: Iranian
Can fluently speak:
Farsi, English
Name: Mr. Mehdi Amani
Position within the company:
Managing Director
Country of Birth:
Iran
Nationality: Iranian
Can fluently speak: Farsi
Name: Mr. Mohamad Ali Mirzakouchak Shirazi
Position within the company:
Member
Country of Birth:
Iran
Nationality: Iranian
Can fluently speak:
Farsi
Company
Activities
Manufacture of Pharmaceutical Raw Material
Local Reporters consider the investigated company to be Medium their field of concern.
Operations
Employees
Company Employs: 60
HQ Premises
Operates from: Owned Offices, Warehouses, Factory
Location: Central
Business Area, Main Road
Branches
Kaveh Industrial City,
Saveh,
Iran
Branch is: Owned
Description of branch: Factory
Imports
Imports: Raw Material
Import%: 20%
Import from: Europe
Import terms: letters of credit
Additional: balance of 80%
purchased via local market
Export
Subject dose not Export
Trading
& Selling
Territory:
100% Nationality
Type of Customer:
Group of companies
Terms of sales:
Cash, letters of credit
Vehicles: Total number of vehicles: 18
Related
Companies
Affiliates:
Alborz Darou Company
4nd Floor, Vozara St, Beheshti Ave
Tehran
Iran
Banks
Export Development Bank of Iran
Tehran
Iran
Bank Tejarat
Tehran
Iran
Financial
Information
Source: Ms. Rahmati (Secretary)
Currency: Iranian Rials - 000,000
|
Months |
Date |
Sales |
Gross |
Net |
|
12 |
29/03/2007 |
48917 |
|
|
|
12 |
29/03/2006 |
45113 |
|
|
|
12 |
29/03/2005 |
40918 |
|
|
Payments
Subject's payments reported to be: NO COMPLAINTS
interview
& reporter comments
Name/Title: Ms. Rahmati (Secretary)
In the interview conducted with Ms. Rahmati (Secretary), she declined bank account numbers citing the grounds of Company confidentiality.
Conclusion
Local Reputation: The company being investigated is considered by local reporters to be a
Medium Trade Risk.
General Conclusion:
Local informants consider granting of credit to be a fair trade risk.
Owner/Shareholders Comments:
Some of owners involved in the running of
the business
Age of Business: Old Business
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)